The impact of insurance status on outcomes after surgery for spinal metastases

Authors

  • Hormuzdiyar H. Dasenbrock MD,

    1. Department of Neurosurgery, Brigham and Women's Hospital, Children's Hospital of Boston, Harvard Medical School, Boston, Massachusetts
    Search for more papers by this author
  • Jean-Paul Wolinsky MD,

    1. Spinal Column Biomechanics and Surgical Outcomes Laboratory, John Hopkins University, Baltimore, Maryland
    2. Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland
    Search for more papers by this author
  • Daniel M. Sciubba MD,

    1. Spinal Column Biomechanics and Surgical Outcomes Laboratory, John Hopkins University, Baltimore, Maryland
    2. Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland
    Search for more papers by this author
  • Timothy F. Witham MD,

    1. Spinal Column Biomechanics and Surgical Outcomes Laboratory, John Hopkins University, Baltimore, Maryland
    2. Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland
    Search for more papers by this author
  • Ziya L. Gokaslan MD,

    1. Spinal Column Biomechanics and Surgical Outcomes Laboratory, John Hopkins University, Baltimore, Maryland
    2. Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland
    Search for more papers by this author
  • Ali Bydon MD

    Corresponding author
    1. Spinal Column Biomechanics and Surgical Outcomes Laboratory, John Hopkins University, Baltimore, Maryland
    2. Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland
    • Department of Neurosurgery, Johns Hopkins University, 600 N Wolfe St, Meyer 5-109, Baltimore, MD 21287
    Search for more papers by this author
    • Fax: (410) 502-3399


Abstract

BACKGROUND:

Disparities based on insurance status in the American health care system are well established. However, to the authors' knowledge, this is the first study to evaluate variables that may explain differences based on payer type in the outcomes after surgery for spinal metastases.

METHODS:

Data from the Nationwide Inpatient Sample (2005-2008) were retrospectively extracted. Patients ages 18 to 64 years who underwent surgery for spinal metastases were included. Multivariate logistic regression was performed to calculate the adjusted odds of in-hospital death and the development of a complication for Medicaid recipients and for those without insurance compared with privately insured patients. All analyses were adjusted for differences in patient age, gender, primary tumor histology, socioeconomic status, hospital bed size, and hospital teaching status.

RESULTS:

A total of 2157 hospital admissions were evaluated. The adjusted odds of in-hospital death were significantly higher for Medicaid recipients (crude rate: 6.5%; odds ratio [OR], 1.79; 95% confidence interval [95% CI], 1.11-2.88 [P = .02]) and uninsured patients (crude rate: 7.7%; OR, 2.15; 95% CI, 1.04-4.46 [P = .04]) compared with privately insured patients (crude rate: 3.8%). Complication rates were also significantly higher for Medicaid recipients (OR, 1.34; 95% CI, 1.04-1.72 [P = .02]). However, after also adjusting for acuity of presentation, the odds of in-hospital death were not significantly different for Medicaid (OR, 1.38; 95% CI, 0.86-2.21 [P = .18]) or uninsured patients (OR, 1.86; 95% CI, 0.90-3.83 [P = .09]); in addition, complication rates did not appear to differ significantly.

CONCLUSIONS:

This nationwide study suggests that disparities based on insurance status for patients undergoing surgery for spinal metastases may be attributable to a higher acuity of presentation. Cancer 2012. © 2012 American Cancer Society

Ancillary